Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

Twenty patients with progressive metastatic solid tumours were entered into a study to evaluate the biological effects and toxicity of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF was given as half-hour intravenous infusions during two 10-day phases of daily tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Steward, W. P., Scarffe, J. H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G., Crowther, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246969/
https://www.ncbi.nlm.nih.gov/pubmed/2667607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246969/
https://www.ncbi.nlm.nih.gov/pubmed/2667607

Ejemplares similares